Cargando…
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
Thyroid malignant neoplasm develops from follicular or parafollicular thyroid cells. A higher proportion of anaplastic thyroid cancer has an adverse prognosis. New drugs are being used in clinical treatment. However, for advanced thyroid malignant neoplasm such as anaplastic thyroid carcinoma, the m...
Autores principales: | Guan, Mingxu, Romano, Gaetano, Coroniti, Roberta, Henderson, Earl E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242545/ https://www.ncbi.nlm.nih.gov/pubmed/25366264 http://dx.doi.org/10.1186/s13046-014-0091-8 |
Ejemplares similares
-
Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapy
por: Guan, Mingxu, et al.
Publicado: (2016) -
Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012) -
Oncolytic virotherapy for pediatric malignancies: future prospects
por: Waters, Alicia M, et al.
Publicado: (2016) -
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021) -
Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022)